What is leukemia Danilo Allegra and Dania Puggioni

Despite advances in medicine,

cancer remains one of the most frightening
diagnoses patients can receive.

What makes it so difficult to cure
is that it’s not one illness,

but a family of over 100 diseases
occurring in different types of cells.

And one type of cancer
has the unfortunate distinction

of afflicting children
more than any other type.

This is leukemia,

a cancer that begins in stem cells
found in the bone marrow.

A stem cell is a bit like an infant,

undeveloped but possessing
great potential.

Many stem cells specialize
and become cells of organs,

like the liver, brain and heart.

But in some tissues,

they can continue to divide into new
stem cells throughout development,

and into adulthood in order to frequently
generate new cells

and keep up with the body’s needs.

One example is the bone marrow,

where stem cells differentiate
into many types of blood cells.

That includes red blood cells,

which carry oxygen
from the lungs to all tissues,

platelets, which help stop bleeding
by sticking to damaged blood vessels,

and white blood cells,

which patrol the body,
destroying potentially harmful invaders.

Every once in a while,

something goes wrong during
a stem cell’s specialization process

and harmful mutations
occur in the cell’s DNA.

Cells with compromised DNA
are supposed to self-destruct,

but some damaged cells ignore this order,

replicating uncontrollably,
even as they lose their original function.

These are what we know as cancer cells.

It is not yet clear why leukemia
is the most common childhood cancer,

but one contributing factor may be

that leukemias are often caused
by just one or two DNA modifications,

while most cancers require many of them,

allowing leukemias to arise faster
than other types of cancer.

Moreover, some DNA alterations
can occur in white blood cells

during fetal development,

further increasing the risk
of early leukemia.

But though it affects more children
than any other cancer,

adults constitute the majority
of leukemia patients overall.

Once leukemia strikes, the damaged cells
reproduce in the blood and the bone marrow

until they take up
all available space and resources.

When the bone marrow
can no longer produce

the required amount of functional cells,

the blood becomes depleted.

The lack of red blood cells

means that muscles
don’t get enough oxygen,

the reduced number of platelets
is not sufficient to repair wounds,

and the dearth of functional white
blood cells impairs the immune system,

increasing the risk of infections.

To restore the normal
function of the blood,

leukemic cells have to be eliminated.

But because leukemias
are not solid tumors,

they can’t be removed surgically.

Instead, the cells are killed
inside the body using various treatments

that include chemotherapy,

a combination of drugs that destroys
quickly multiplying cells.

Unfortunately, this has the side effect
of killing healthy cells,

such as those found in hair follicles
or intestines.

And in some cases, the dosage
required is so high

that it kills all cells
in the bone marrow,

including stem cells.

When this happens, the body is no longer
able to create new blood cells on its own.

Fortunately, outside help can come
in the form of stem cells

from the bone marrow of a donor.

Once transplanted into the patient,

they rapidly repopulate
the bone marrow and the blood.

However, bone marrow transplants
are a complicated process

requiring antigen compatibility
between the donor and recipient

to keep the transplanted cells from
from attacking the patient’s own cells

as foreign bodies.

Unlike with blood transplants,

there are thousands of HLA types,

and even siblings and close relatives
may not have compatible bone marrow.

If this is the case, the search
is expanded to a database

containing the genetic makeup of millions
of voluntary bone marrow donors.

The more potential donors there are,

the more patients lives can be saved
through successful transplants.

Leukemia may be a frightening disease,
but there is strength and hope in numbers.

尽管医学取得了进步,但

癌症仍然是患者可以接受的最可怕的
诊断之一。

难以治愈
的原因在于它不是一种疾病,

而是
发生在不同类型细胞中的 100 多种疾病的家族。

不幸

的是,一种癌症对儿童的影响
比其他任何癌症都多。

这是白血病,

一种起源于骨髓干细胞的癌症

干细胞有点像婴儿,

尚未发育,但
潜力巨大。

许多干细胞特化
并成为器官细胞,

如肝脏、大脑和心脏。

但在某些组织中,

它们可以
在整个发育过程中继续分裂成新的干细胞,

并进入成年期,以便频繁
产生新细胞

并满足身体的需要。

一个例子是骨髓,

其中干细胞分化
成多种类型的血细胞。

其中包括

将氧气
从肺部输送到所有组织的

红细胞、
通过粘附在受损血管上帮助止血的血小板,

以及

在体内巡逻、
消灭潜在有害入侵者的白细胞。

每隔一段时间,

干细胞的特化过程就会

出现问题,细胞的 DNA 会发生有害的突变。

DNA受损的
细胞应该会自我毁灭,

但一些受损的细胞会忽略这个顺序,

不受控制地复制,
即使它们失去了原来的功能。

这些就是我们所知的癌细胞。

目前尚不清楚为什么白血病
是最常见的儿童癌症,

但一个促成因素可能

是白血病通常
仅由一两个 DNA 修饰引起,

而大多数癌症需要其中的许多修饰,这

使得白血病
比其他类型的癌症发生得更快。 癌症。

此外,

在胎儿发育过程中,白细胞中可能会发生一些 DNA 改变,

进一步增加
早期白血病的风险。

但是,尽管它对儿童的影响
比任何其他癌症都多,


总体而言,成人占白血病患者的大多数。

一旦白血病发作,受损细胞就会
在血液和骨髓中繁殖,

直到它们占用
所有可用空间和资源。

当骨髓
不再能

产生所需数量的功能细胞时

,血液就会枯竭。

红细胞的缺乏

意味着
肌肉得不到足够的氧气,

血小板数量的减少
不足以修复伤口,

功能性白细胞的缺乏
会损害免疫系统,

增加感染的风险。

为了恢复血液的正常
功能,

必须清除白血病细胞。

但由于白血病
不是实体瘤,

它们不能通过手术切除。

取而代之的是,
使用包括化学疗法在内的各种疗法在体内杀死细胞

,化学疗法是

一种破坏
快速增殖细胞的药物组合。

不幸的是,这具有
杀死健康细胞的副作用,

例如在毛囊
或肠道中发现的细胞。

在某些情况下,
所需的剂量非常高

,以至于会杀死
骨髓中的所有细胞,

包括干细胞。

当这种情况发生时,身体不再
能够自行产生新的血细胞。

幸运的是,外部帮助可以

来自捐赠者骨髓的干细胞。

一旦移植到患者体内,

它们会迅速重新填充
骨髓和血液。

然而,骨髓移植
是一个复杂的过程,

需要
供体和受体之间的抗原相容性,

以防止移植
的细胞作为异物攻击患者自身的细胞

与血液移植不同,

有数千种 HLA 类型,

甚至兄弟姐妹和近亲
也可能没有相容的骨髓。

如果是这种情况,搜索
将扩展到

包含数
百万自愿骨髓捐献者的基因组成的数据库。

潜在的捐赠者越多,通过成功移植

挽救的患者生命就越多

白血病可能是一种可怕的疾病,
但人数却充满力量和希望。